Anthony Vale is of counsel in the Health Sciences Department of Pepper Hamilton LLP, and is a Fellow of the Pepper Center for Public Service. He has many years’ experience in complex litigation involving pharmaceuticals, medical devices and other products. He was trial counsel in Tadai v. Eli Lilly and Co. (Los Angeles Superior Court), which resulted in a defense verdict in November 2011.
Mr. Vale has played a major role in MDLs in which Pepper was national counsel, which have involved many class actions: In Re Allura Fiber Cement Siding Products Liability Litigation, MDL 2886; In Re: CertainTeed Fiber Cement Siding Litig., MDL 2270; In Re: Avandia Marketing, Sales Practices and Prods. Liab. Litig., MDL 1871; In Re: Human Tissue Prods. Liab. Litig., MDL 1763; In Re: Zyprexa Prods Liab. Litig., MDL 1596; In Re: Orthopedic Bone Screw Prods Liab. Litig., MDL 1014; TMJ Litigation, MDL 1001; In Re Sunrise Securities Litigation, MDL 655.
In immigration cases, Mr. Vale has represented many non-citizens who seek asylum or relief from removal. He has been successful in cases on behalf of non-citizens from Angola, Cameroon, El Salvador Guatemala and Honduras. Yoc-Us v. AG United States, 2019 U.S. App. LEXIS 22736 (3d Cir. July 31, 2019); Duncan v. Barr, 919 F3d 209 (4th Cir. 2019); Osorio-Martinez v. AG United States, 893 F.3d 153 (3d Cir. 2018).